The markets opened flat with the Dow adding 3 points to 20,825 as pending home sales fell in January. Nasdaq held steady at 5,845.
On the upside
La Jolla Pharmaceutical (Nasdaq: LJPC) reported positive results from the ATHOS-3 Phase 3 study of LJPC-501 in patients with catecholamine resistant hypotension.
Gogo (Nasdaq: GOGO) narrowed losses for the fourth quarter as revenue rose.
Cellectar Biosciences (Nasdaq: CLRB) provided an update of its Phase 1 clinical study of CLR 131 to treat relapsed or refractory multiple myeloma.
On the downside
Fourth quarter earnings for AmTrust Financial Services (Nasdaq: AFSI) fell short of expectations.
Shutterstock (NYSE: SSTK) reported fourth quarter earnings and revenue that missed expectations.
BioCryst Pharmaceuticals (Nasdaq: BCRX) reported a loss for the fourth quarter.
In the broad market, advancing issues outpaced decliners by a margin of more than 7 to 5 on the NYSE and by nearly 5 to 3 on Nasdaq. The broader S&P 500 index eased a fraction to 2,366. Bitcoin climbed $12 to $1,175.
